Literature DB >> 19713291

Sodium bicarbonate for the prevention of contrast induced-acute kidney injury: a systematic review and meta-analysis.

Somjot S Brar1, Swapnil Hiremath, George Dangas, Roxana Mehran, Simerjeet K Brar, Martin B Leon.   

Abstract

BACKGROUND AND OBJECTIVES: Infusion of sodium bicarbonate has been suggested as a preventative strategy but reports are conflicting on its efficacy. The aim of this study was to assess the effectiveness of hydration with sodium bicarbonate for the prevention of contrast-induced acute kidney injury (CI-AKI). DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Medline, EMBASE, Cochrane library, and the Internet were searched for randomized controlled trials comparing hydration between sodium bicarbonate and chloride for the prevention of CI-AKI between 1966 and November 2008. Fourteen trials that included 2290 patients were identified. There was significant heterogeneity between studies (P heterogeneity = 0.02; I(2) = 47.8%), which was largely accounted for by trial size (P = 0.016). Trials were therefore classified by size.
RESULTS: Three trials were categorized as large (n = 1145) and 12 as small (n = 1145). Among the large trials, the incidence of CI-AKI for sodium bicarbonate and sodium chloride was 10.7 and 12.5%, respectively; the relative risk (RR) [95% confidence interval (CI)] was 0.85 (0.63 to 1.16) without evidence of heterogeneity (P = 0.89, I(2) = 0%). The pooled RR (95% CI) among the 12 small trials was 0.50 (0.27 to 0.93) with significant between-trial heterogeneity (P = 0.01; I(2) = 56%). The small trials were more likely to be of lower methodological quality.
CONCLUSIONS: A significant clinical and statistical heterogeneity was observed that was largely explained by trial size and published status. Among the large randomized trials there was no evidence of benefit for hydration with sodium bicarbonate compared with sodium chloride for the prevention of CI-AKI. The benefit of sodium bicarbonate was limited to small trials of lower methodological quality.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19713291      PMCID: PMC2758263          DOI: 10.2215/CJN.03120509

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  29 in total

Review 1.  Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses.

Authors:  D Moher; D J Cook; S Eastwood; I Olkin; D Rennie; D F Stroup
Journal:  Lancet       Date:  1999-11-27       Impact factor: 79.321

2.  Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature.

Authors:  J A Sterne; D Gavaghan; M Egger
Journal:  J Clin Epidemiol       Date:  2000-11       Impact factor: 6.437

3.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

4.  Renal Insufficiency Following Radiocontrast Exposure Trial (REINFORCE): a randomized comparison of sodium bicarbonate versus sodium chloride hydration for the prevention of contrast-induced nephropathy.

Authors:  Esther Adolph; Birgit Holdt-Lehmann; Tushar Chatterjee; Susanne Paschka; Andreas Prott; Henrik Schneider; Thomas Koerber; Hüseyin Ince; Michael Steiner; Peter Schuff-Werner; Christoph A Nienaber
Journal:  Coron Artery Dis       Date:  2008-09       Impact factor: 1.439

Review 5.  Pathogenesis of contrast-induced nephropathy: experimental and clinical observations with an emphasis on the role of osmolality.

Authors:  Michael R Rudnick; Stanley Goldfarb
Journal:  Rev Cardiovasc Med       Date:  2003       Impact factor: 2.930

Review 6.  Radiocontrast nephropathy: identifying the high-risk patient and the implications of exacerbating renal function.

Authors:  Eugenia Nikolsky; Eve D Aymong; George Dangas; Roxana Mehran
Journal:  Rev Cardiovasc Med       Date:  2003       Impact factor: 2.930

7.  A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation.

Authors:  Roxana Mehran; Eve D Aymong; Eugenia Nikolsky; Zoran Lasic; Ioannis Iakovou; Martin Fahy; Gary S Mintz; Alexandra J Lansky; Jeffrey W Moses; Gregg W Stone; Martin B Leon; George Dangas
Journal:  J Am Coll Cardiol       Date:  2004-10-06       Impact factor: 24.094

8.  The continuing unethical conduct of underpowered clinical trials.

Authors:  Scott D Halpern; Jason H T Karlawish; Jesse A Berlin
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

9.  Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial.

Authors:  Gregory J Merten; W Patrick Burgess; Lee V Gray; Jeremiah H Holleman; Timothy S Roush; Glen J Kowalchuk; Robert M Bersin; Arl Van Moore; Charles A Simonton; Robert A Rittase; H James Norton; Thomas P Kennedy
Journal:  JAMA       Date:  2004-05-19       Impact factor: 56.272

Review 10.  Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis.

Authors:  Sankar D Navaneethan; Sonal Singh; Suresh Appasamy; Richard E Wing; Ashwini R Sehgal
Journal:  Am J Kidney Dis       Date:  2008-11-22       Impact factor: 8.860

View more
  38 in total

1.  Prevention of contrast-induced AKI--the ongoing saga.

Authors:  Usman Baber; Roxana Mehran
Journal:  Nat Rev Nephrol       Date:  2012-03-13       Impact factor: 28.314

2.  Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version : JSN, JRS, and JCS Joint Working Group.

Authors:  Iwao Ohno; Hiromitsu Hayashi; Kazutaka Aonuma; Masaru Horio; Naoki Kashihara; Hirokazu Okada; Yasuhiro Komatsu; Shozo Tamura; Kazuo Awai; Yasuyuki Yamashita; Ryohei Kuwatsuru; Atsushi Hirayama; Yoshihiko Saito; Toyoaki Murohara; Nagara Tamaki; Akira Sato; Tadateru Takayama; Enyu Imai; Yoshinari Yasuda; Daisuke Koya; Yoshiharu Tsubakihara; Shigeo Horie; Yukunori Korogi; Yoshifumi Narumi; Katsumi Hayakawa; Hiroyuki Daida; Koichi Node; Isao Kubota
Journal:  Clin Exp Nephrol       Date:  2013-08       Impact factor: 2.801

3.  Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version. JSN, JRS, and JCS Joint Working Group.

Authors:  Iwao Ohno; Hiromitsu Hayashi; Kazutaka Aonuma; Masaru Horio; Naoki Kashihara; Hirokazu Okada; Yasuhiro Komatsu; Shozo Tamura; Kazuo Awai; Yasuyuki Yamashita; Ryohei Kuwatsuru; Atsushi Hirayama; Yoshihiko Saito; Toyoaki Murohara; Nagara Tamaki; Akira Sato; Tadateru Takayama; Enyu Imai; Yoshinari Yasuda; Daisuke Koya; Yoshiharu Tsubakihara; Shigeo Horie; Yukunori Korogi; Yoshifumi Narumi; Katsumi Hayakawa; Hiroyuki Daida; Koichi Node; Isao Kubota
Journal:  Jpn J Radiol       Date:  2013-08       Impact factor: 2.374

4.  Guideline on the use of iodinated contrast media in patients with kidney disease 2018.

Authors:  Yoshitaka Isaka; Hiromitsu Hayashi; Kazutaka Aonuma; Masaru Horio; Yoshio Terada; Kent Doi; Yoshihide Fujigaki; Hideo Yasuda; Taichi Sato; Tomoyuki Fujikura; Ryohei Kuwatsuru; Hiroshi Toei; Ryusuke Murakami; Yoshihiko Saito; Atsushi Hirayama; Toyoaki Murohara; Akira Sato; Hideki Ishii; Tadateru Takayama; Makoto Watanabe; Kazuo Awai; Seitaro Oda; Takamichi Murakami; Yukinobu Yagyu; Nobuhiko Joki; Yasuhiro Komatsu; Takamasa Miyauchi; Yugo Ito; Ryo Miyazawa; Yoshihiko Kanno; Tomonari Ogawa; Hiroki Hayashi; Eri Koshi; Tomoki Kosugi; Yoshinari Yasuda
Journal:  Clin Exp Nephrol       Date:  2020-01       Impact factor: 2.801

Review 5.  Prevention of Contrast and Radiation Injury During Coronary Angiography and Percutaneous Coronary Intervention.

Authors:  Arash Ehteshami Afshar; Puja B Parikh
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-03-22

6.  Preventive Strategies for Contrast-Induced Acute Kidney Injury: And the Winner Is….

Authors:  Sripal Bangalore; Carlo Briguori
Journal:  Circ Cardiovasc Interv       Date:  2017-05       Impact factor: 6.546

Review 7.  Renal imaging in patients with renal impairment.

Authors:  Jason A Poff; Elizabeth M Hecht; Parvati Ramchandani
Journal:  Curr Urol Rep       Date:  2011-02       Impact factor: 3.092

Review 8.  Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines.

Authors:  Fulvio Stacul; Aart J van der Molen; Peter Reimer; Judith A W Webb; Henrik S Thomsen; Sameh K Morcos; Torsten Almén; Peter Aspelin; Marie-France Bellin; Olivier Clement; Gertraud Heinz-Peer
Journal:  Eur Radiol       Date:  2011-08-25       Impact factor: 5.315

9.  Guideline on the use of iodinated contrast media in patients with kidney disease 2018.

Authors:  Yoshitaka Isaka; Hiromitsu Hayashi; Kazutaka Aonuma; Masaru Horio; Yoshio Terada; Kent Doi; Yoshihide Fujigaki; Hideo Yasuda; Taichi Sato; Tomoyuki Fujikura; Ryohei Kuwatsuru; Hiroshi Toei; Ryusuke Murakami; Yoshihiko Saito; Atsushi Hirayama; Toyoaki Murohara; Akira Sato; Hideki Ishii; Tadateru Takayama; Makoto Watanabe; Kazuo Awai; Seitaro Oda; Takamichi Murakami; Yukinobu Yagyu; Nobuhiko Joki; Yasuhiro Komatsu; Takamasa Miyauchi; Yugo Ito; Ryo Miyazawa; Yoshihiko Kanno; Tomonari Ogawa; Hiroki Hayashi; Eri Koshi; Tomoki Kosugi; Yoshinari Yasuda
Journal:  Jpn J Radiol       Date:  2020-01       Impact factor: 2.374

10.  Randomized Trial of Bicarbonate or Saline Study for the Prevention of Contrast-Induced Nephropathy in Patients with CKD.

Authors:  Richard Solomon; Paul Gordon; Steven V Manoukian; J Dawn Abbott; Dean J Kereiakes; Allen Jeremias; Michael Kim; Harold L Dauerman
Journal:  Clin J Am Soc Nephrol       Date:  2015-07-16       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.